Healthcare and Pharmaceuticals industry sector was a confined sector in the past, the command line was neat and clean. Strong regulatory authorities were present in the center. They were prescribing solutions. Market regulatory forces were taking care of the honest distribution and balancing the interests of all the stakeholders. The meteoric rise in the inventions and the arrival of the parallel technologies has changed the complexion of the market and made it more competitive.
The basic levels of the healthcare are increasing; big organizations are ensuring a kind of penetration for the same. When we check it on the scale of the socio-political equations then we find that this industry sector mainly thrives on a demand generation which is positive for the society. Many countries of the world treat it as a fundamental right for their citizens. It has become a social responsibility for many countries where they are trying their level best to match the steps with the needs that are arising.
The sector of the healthcare is flourishing because a consultancy to an expert is short is supply. It also means that an expert can put a price tag on himself. However, it is not the same with medicines. The market of the medicines is full of options and this is why a price competition is on. This price competition is bringing out the worst phase of the market.
The third world countries of the world are generating more demand for healthcare sector because of their unhygienic living standards. They are also the worst sufferer in the terms of per capita penetration to the healthcare facilities. Right from digital technology to the unconventional cures, everything is coming up as a competitor for this sector. Even then a natural increase in the population is creating a new market for this segment and making it fruitful for the investor that has already invested in it.